This confirms what researchers have suspected with mounting evidence about harms caused by the virus.
Federal health officials confirmed Wednesday that the Zika virus causes a rare birth defect and other severe fetal abnormalities, marking a turning point in an epidemic that has spread to nearly 40 countries and territories in the Americas and elsewhere.
Scientists at the Centers for Disease Control and Prevention conducted a careful review of existing research and agreed that the evidence was conclusive, Director Thomas Frieden said. It is the first time a mosquito-borne virus has been linked to congenital brain defects.
"It is now clear, and CDC has concluded, that the virus causes microcephaly," Frieden said. CDC is launching more studies to determine whether children with that rare condition, which is characterized at birth by an abnormally small head, represent the "tip of the iceberg of what we could see in damaging effects on the brain and other developmental problems."
Orange Healthcare, entité dédiée à la stratégie santé du groupe Orange, concentre son expertise autour de trois domaines d’intervention : les services pour les professionnels de santé, les services de télésanté et les services de prévention. Orange Healthcare est un partenaire technologique privilégié du secteur de la santé, il contribue à moderniser les infrastructures de santé mais également les systèmes de soins dans leur ensemble, en équippant les établissements de santé en solutions de communication au niveau national et international. Hébergement et sécurisation des données informatisées des patients, meilleure gestion des matériels médicaux, amélioration de l’accueil des patients, perfectionnement du parcours patient et équipement multimédia, télésuivi des maladies chroniques, services de maintien à domicile, accompagnement de la perte d'autonomie, services de télémédecine sont autant de réponses qu’Orange Healthcare se propose d’apporter au monde médical à travers ses offres.
Pfizer is betting big on the Internet of Things, or IoT, in medicine – that is, the connectivity of physical objects like medical devices to collect and exchange data – to boost Parkinson’s R&D and ultimately, to better inform care for patients.
To make this nebulous idea a reality, the pharmaceutical company is partnering with computer titan IBM to develop a system of sensors, mobile devices and machines that could deliver real-time, around-the-clock disease symptom monitoring of Parkinson’s patients to clinicians and researchers.
Peter Bergethon, vice president and head of quantitative medicine at Pfizer, explained that Pfizer’s interest in an IoT it twofold: research and commercial. The company will first pilot the system in a clinical trial setting, and eventually, Pfizer wants to pursue a regulatory path for its IoT to market it to healthcare providers.
“We need to understand not just why we’re making someone symptomatically better, but we also need to identify earlier on who needs the drug and if we’ll be able to make a difference in the disease progression,” Bergethon said in an interview.
Pfizer is aiming to begin a clinical trial using the IoT in 2018 and enroll up to 200 research participants, both control subjects and those with Parkinson’s disease who are already taking existing therapies to manage their symptoms.
Bergethon explained that Pfizer chose to pilot this ambitious project in Parkinson’s patients because the disease requires frequent adjustment to medication depending on how the disease is progressing and how the patient is responding. The fact that the technology needed to measure motion in movement disorders already exists and is quite advanced was also a major factor.
Pfizer and IBM haven’t built its IoT prototype yet, and Bergethon told me he couldn’t yet divulge details on what it might physically look like. But he explained that the remote monitoring solution would be easy to use and noninvasive so that patients could use it at home in their daily lives without the help of a clinician or other aide. For example, patients might place a wearable sensor on their elbow or wrist. That sensor would be connected to other sensors, medical devices and applications through online computer networks.
That system will measure a range of health indicators, including motor function, dyskinesia, cognition, sleep and daily activities such as grooming, dressing and eating. By monitoring this data, clinicians ideally would be able to better understand the effect of a patient’s medication as the disease progresses, enabling them to adjust the patient’s treatment regimen as needed. In a research setting, data generated through the system could provide drug developers with real-world evidence needed to accelerate new and better therapies.
Currently, clinicians rely on getting these types of observations and changes in health from patient anecdotes during doctors’ visits. Needless to say, that information can be subjective and unreliable.
Suivre son poids avec une balance intelligente, contrôler sa glycémie avec une appli... Les outils de santé mobile font partie de notre quotidien e
Via LEO INNOVATION LAB FRANCE
Sandra Boyer's insight:
Il existe actuellement environ 100 000 applications santé disponibles dans le monde sur l’App Store et Google Play, dont plus de 1000 en français. Rien d’étonnant à ce que 70 % des mobinautes santé déclarent ne pas avoir trouvé l’appli qui leur convient ! Et quand ils pensent l’avoir trouvée, 46 % la désinstallent après le premier usage, et 90 % après le 5ème lancement pour cause de déception…
While mobile apps are new enough on the care delivery scene that many providers have only begun dabbling, consumers are sending a strong message that forward-thinking hospital executives can translate into an opportunity for improving population health management programs.Northwestern University's Feinberg School of Medicine is conducting clinical trials that use mobile health apps to do much more than just communicate with patients — the software teaches mental health patients cognitive behavioral therapy, or CBT, techniques designed to improve population health and reduce mental healthcare costs.This story is part of a reporting package on the rise of population in health in healthcare IT management. Stories include our analysis of health system strategies, an overview of the work done by Essentia Health and a look at how mobile apps are supporting initiatives.Designed by Northwestern's Center for Behavioral Intervention Technologies, the ThinkFeelDo website (a responsive design site built to render effectively on any device) and the IntelliCare suite of mobile apps (available in the Google Play store for Android devices, with Apple iOS apps in the works) break up the various CBT techniques into separate modules to make learning the techniques and applying them in situations an easier task.The modules include text, animation and video. Caregiver coaches, on the other end of the mobile site and apps, review patient progress and can intervene during lessons to help patients with any challenges or issues and to provide encouragement."Costs can be saved by giving depressed patients these kinds of tools, decreasing overall health care utilization for an individual," said Kenneth R. Weingardt, scientific director at the Center for Behavioral Intervention Technologies. Weingardt also is a licensed psychologist."We are now saving more money because the cost of the app is much lower than the cost of face-to-face. For some folks who are fairly well-functioning and can go it alone, these types of technology may provide them with what they need so they do not have a long depressive episode that impacts their health and costs a health plan money."ThinkFeelDo and IntelliCare are still in clinical trials at Northwestern, though CBITs is in discussions with Kaiser about deploying IntelliCare through its patient portal."Mobile interventions have much farther reach than individual providers can have," Weingardt said. "They can reach many more people beyond those we can see in our clinic. And a health system that adopts these kinds of tools can improve their bandwidth and their ability to address these problems beyond the capacity of their workforce.”[Like Healthcare IT News on Facebook]In the Northwestern’s clinical trials, Weingardt added, that means giving participants tools to get symptoms under control and making it less likely they will come back with complaints.Providers such as Northwestern and other simply cannot ignore the trend toward mobile tools any longer, said population health management vendor Enli Health Intelligence chief medical officer Joseph Siemienczuk, MD."We have to follow the communication preferences of the community and and it is clear that their communication preferences have moved to mobile technology,” Siemienczuk said. "As we pursue effectiveness, moving patient engagement activities to mobile technology is an imperative."Twitter: @SiwickiHealthIT
Via Alex Butler
[Note: "MCC" stands for "Medical Communications Company" - a commercial for-profit entity]
WebMD is the most popular source of health information in the US, and is likely to dominate your Google search results for almost any medical question you have. According to its editorial policy, WebMD promises to empower patients and health professionals with "objective, trustworthy, and accurate health information."
But is WebMD actually trustworthy?
The only high-quality study I could find that related to the question of WebMD's independence was published in JAMA in 2013. The researchers looked at which medical communication companies targeting doctors received the most money from 14 pharmaceutical and device companies. They found WebMD, along with its sister site Medscape, were the top recipients of industry dollars (see chart).
I asked James Yeh, a physician-researcher based at Brigham and Women's Hospital who has studied the influence of industry funding on medical information, what this reveals about the site. "This puts [WebMD] in a conflict of interest," he said. "Maybe they are trying to educate the clinician or the public, but at the same time there’s the marketing side: They are also trying to sell a drug."
But over the years, others have questioned — and found reason to critique — the site's cozy ties to drugmakers. In 2010, Sen. Chuck Grassley sent a letter to the site after finding that a WebMD quiz for depression, sponsored by pharmaceutical company Eli Lilly, was rigged to suggest everybody who took the test was at risk for major depression. Naturally, that would make them a potential candidate for antidepressants, conveniently manufactured by Eli Lilly.
KEY TAKEAWAY: While most pharma companies are staying on the sideline when it come to social media Takeda Oncology is using Twitter to raise awareness around Multiple Myeloma.
Via Michael Lucht - www.b-innovative.eu
Running a healthcare organization is already a complex job. According to some experts, it is getting more complicated. Beyond operations, budgets, marketing, personnel, and regulatory compliance issues, now executives and managers must consider social networking.
According to a Forbes blog interview with cardiologist Dr. Kevin Campbell, who is active on broadcast media and on social media, patients can improve their health though smart use of social media. That is because outlets like Twitter, Facebook, and blogs can provide information that is critical to patients.
Social media provides patients an opportunity to easily interact with physicians, nurses and other patients. Blogging sites afford patients with the opportunity to express opinions and share “patient experiences.” These often provide patients with a great source of information about a particular physician, hospital or procedure. Twitter allows patients to interact and discuss conditions and experiences in “real time”.
Care-providing organizations have also begun to use social media as a way to help patients, according to Shannon Dosemagen, director of community engagement, education and outreach of Public Laboratory for Open Technology and Science and Lee Aase, director of the Mayo Clinic Center for Social Media and its Social Media Health Network. “Social media has provided a space to share preventative information and enabled the creation of support structures to track personal health and build patient-to-patient support networks post-diagnosis,” they wrote in an article.
Communications is a foundation of any form of treatment, preventative action, or awareness, and social media provides new tools for enabling better availability of information. However, there are potential issues. One is that social media enables two-way communications and anyone can begin to spread information. There have been many cases where people who are more skilled at social media than science and fact have disseminated significant amounts of misinformation about diet, vaccines, and other topics. This will happen in any case, so part of the responsibility of care organizations becomes helping to correct the record and offer the best levels of help and guidance possible. Correct use of social media became an important part of fighting the Ebola crisis a couple of years ago.
There are other considerations as well, including managing privacy issues that can come about from media sharing including maintaining a brand and balancing the voices of both the institution and the employees. Creating an effective and safe social media strategy is not something that happens by delegating the Twitter feed to someone junior. All managers must understand how the technology plays into strategy and learn how to make it work for patients and the organization.
Are you interested in finding a rewarding and lucrative healthcare career that fits your individual strengths and interests? Find out how education can help you adapt to the changing healthcare landscape. American Sentinel University is an innovative, accredited provider of healthcare management degrees, including an MBA Healthcare and Master of Science Business Intelligence and Analytics.
Global pharma company Takeda is another example of a leading company that is pursuing new applications of digital technology to develop solutions to the challenges facing healthcare, both here in Japan and around the world.
Takeda and its “Start-Up Incubator” With more than 30,000 employees, a presence in 70 countries and products across a wide range of therapeutic areas, Takeda is constantly looking for new ways to bring new value to patients as part of its patient-centric culture. One of these ways is its approach to digital strategy and technology.
Takeda has embedded digital strategy into its DNA with a model it calls the "Takeda Digital Accelerator”," designed to provide investment to new ideas that apply key customer digital trends to the healthcare space, with the goal of generating patient-centric innovations that can drive stronger outcomes. Its foundation is in digital experimentation, where new ways of thinking and working are discovered by testing and learning.
First, Takeda assembles the teams and resources needed for this experimentation to take place. Then, different teams work on small, local challenges, which they test using specific hypothesis. These findings are then incubated and shared acros the Takeda community, where other teams can leverage them.
Another way this Digital Accelerator model works is through the global ecosystem of external partners Takeda has built over the years. These partners are also helpe make recommendations and solutions to healthcare challenges, and the findings are incubated, tested and shared across the larger network.
This kind of forward thinking helps Takeda identify, explore and experiment with new ways of digitizing the healthcare experience in ways that ultimately benefit patients.
As patients continue to grow more comfortable in a digital world and more savvy about their health care options, pharmaceutical manufacturers are changing their sales models, according to a recent study.
Best Practices, LLC, surveyed 39 digital marketers at 30 large and small pharmaceutical companies to examine the most effective marketing strategies, identify innovative approaches and look for trends. “Key Trends & Innovative Activities in Biopharma Digital Marketing” included use of mobile and social media, wearable devices, electronic records and digital customer service models.
“Pharmaceutical companies have to meet the growing number of educated patients who are out in the digital world,” said Cameron Tew, who heads research services and business operations for Best Practices, a North Carolina-based research firm. “What we’re seeing is the business model has changed quite a bit. They’re not sending in a single sales rep with that one product. Now, it’s a much broader group of people who are working at the provider level or educator level and talking more about the science of their products.”
The survey included 13 companies with 2014 revenue of more than $10 billion, such as AstraZeneca, Merck and Novartis. The balance of the companies surveyed had less than $10 million in revenue for 2014, including Biogen, Abbott and Baxter.
The study showed that the top three marketing channels for healthcare providers are e-marketing, e-presentations and point-of-care apps that allow health care providers to use mobile devices to check medical history or develop treatment plans based on patient needs.
Sharing your scoops to your social media accounts is a must to distribute your curated content. Not only will it drive traffic and leads through your content, but it will help show your expertise with your followers.
How to integrate my topics' content to my website?
Integrating your curated content to your website or blog will allow you to increase your website visitors’ engagement, boost SEO and acquire new visitors. By redirecting your social media traffic to your website, Scoop.it will also help you generate more qualified traffic and leads from your curation work.
Distributing your curated content through a newsletter is a great way to nurture and engage your email subscribers will developing your traffic and visibility.
Creating engaging newsletters with your curated content is really easy.